Status:
COMPLETED
Vaginal Infection Study 2
Lead Sponsor:
Lumara Health, Inc.
Conditions:
Vaginal Infection
Eligibility:
FEMALE
16+ years
Phase:
PHASE3
Brief Summary
This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.
Eligibility Criteria
Inclusion
- Patients must have a clinical diagnosis of vaginal infection.
- Patients must be post-menopausal, surgically sterilized or using an acceptable form of birth control.
Exclusion
- Patients must not have any other infections
- May not be pregnant or nursing
- May not be receiving any other antimicrobial therapies or any medications that would interfere with the outcome of the study.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
843 Patients enrolled
Trial Details
Trial ID
NCT00694928
Start Date
May 1 2008
End Date
November 1 2009
Last Update
March 5 2012
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Brookwood Ob-GYN, PC/Women's Medical Plaza
Birmingham, Alabama, United States, 35209
2
Drug Research Analysis Corp
Montgomery, Alabama, United States, 36106
3
Drug Research and Analysis Corp.
Montgomery, Alabama, United States, 36106
4
Ob/Gyn Associates
Jonesboro, Arkansas, United States, 72401